Accelerated approval based on data demonstrating clinically meaningful efficacy, including a 42 percent overall response rate (95 percent confidence interval, 32–52 percent)1First advancement...
A groundbreaking, first-of-its-kind advancement marks a new era in reverse shoulder arthroplasty, culminating in eight years of US clinical investigation and regulatory...
The final rule preserves access to care by mitigating proposed cuts to orthopaedic proceduresWASHINGTON, Nov. 4, 2026 /PRNewswire/ -- The American Association...
GaNrich provides GaN-on-Si and GaN-on-Sapphire platforms, combined with proprietary technology, full-range capability, and non-red supply chain strategy. TAIPEI and BERLIN and NEW...
